Skip to main content

Table 3 Recovery period profiles

From: Effect of topical ropivacaine on the response to endotracheal tube during emergence from general anesthesia: a prospective randomized double-blind controlled study

 

Group C

Group R

P

Eye-opening time (min)

14.92 ± 10.47

14.19 ± 9.96

0.798

Extubated time (min)

19.46 ± 10.08

18.69 ± 9.95

0.783

PACU standing time (min)

50.77 ± 15.07

49.69 ± 15.36

0.800

Agitation (number)

0

0

 

Nausea and vomiting (number)

0

0

 

Hypertension

4 (15.38%)

5 (19.23%)

0.500

  1. Categorical variables were presented as numbers and percentage, quantitative variables were shown as means and standard deviation. ASA = American Society of Anesthesiologists. Group R: the patients were recieved 6 ml of 0.75% ropivacaine for throat, glottic area and tracheal mucosa uniform spray; Group C: the patients were recieved with 6 ml of saline for throat, glottic area and tracheal mucosa uniform spray as control